About

Company description

Sai Life Sciences is a full-service CDMO driven by a vision to support the launch of 25 new medicines by 2025.  It works with innovator pharma and biotech companies across USA, EU & Japan, accelerating the discovery, development and manufacture of complex small molecules. Over the past two decades, Sai Life Sciences has consistently delivered on a diverse set of NCE development programs for its customers with a track record of bringing value based on quality, pricing and responsiveness. Today, as one of India’s fastest growing CDMO companies, Sai Life Sciences works with the leading large pharma companies, as well as several small and mid-sized pharma & biotech companies. Sai Life Sciences is backed by committed long-term investors, TPG Capital and HBM Healthcare Investments.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Advanced Intermediates |Analytical Chemistry |Analytical Chemistry More

Upcoming events

16 mar 2020

CPhI Japan 2020

16 - 18 March 2020 Tokyo, Japan Visit us at stand 1C-50 Book a meeting See our Exhibitor Profile   See full Exhibitor List
13 oct 2020

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 7F60 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 101B50 See our Exhibitor Profile   See full Exhibitor List
18 mar 2019

CPhI Japan 2019

18 - 20 March 2019 Tokyo, Japan We were at stand 2F-29 See our Exhibitor Profile   See full Exhibitor List

News about Sai Life Sciences

Sai Life Sciences to recruit 300+ scientists for its upcoming research facility

31 Jan 2020

Sai Life Sciences to recruit 300+ scientists for its upcoming research facility

Sai Life Sciences has initiated the recruitment of 300+ scientists for its upcoming integrated Research & Technology (R&T) centre in Hyderabad, India. This will result in doubling the full-time equivalents (FTEs) in the areas of discovery chemistry, process chemistry and analytical chemistry.

Read more

20 Jan 2020

Meet Sai Life Sciences at CPhI, Japan 2020

Sai Life Sciences will be in Tokyo for CPhI Japan 2020 during March 16-18, 2020. Please visit booth # 1C - 50 and explore opportunities for collaboration. To schedule an appointment, email [email protected]

Read more

10 Jan 2020

Jay Stella joins Sai Life Sciences as Chief Business Officer

Sai Life Sciences, one of India’s fastest growing Contract Development & Manufacturing Organizations (CDMOs), announced the appointment of Jay Stella as Chief Business Officer, to lead the overall business development and program management for the company.

Read more

10 Jan 2020

Dr. Mark Bittinger joins Sai Life Sciences as Global Head of Biology

Dr. Mark Bittinger has joined Sai Life Sciences as Vice President and Global Head of Biology. Mark will be based out of companys' new Discovery Biology facility in Cambridge, Massachusetts, USA, which provides exploratory biology capabilities to the expanding array of start-up and biotech companies in the region.

Read more